Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT05516966 · COMPLETED
Trial details
- NCT number
- NCT05516966
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2023-05-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.